Anika Therapeutics, Inc. Tax Withholding Paid on Stock Awards
Anika Therapeutics, Inc. (ANIK) reported Tax Withholding Paid on Stock Awards of $1.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-29
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $58.00K, a 29.27% decline year-over-year.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $1.66M, a 12.95% increase year-over-year.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $4.00K, a 94.74% decline year-over-year.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $13.00K, a 40.91% decline year-over-year.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.57M, a 39.75% decline from fiscal 2024.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.60M, a 20.77% increase from fiscal 2023.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.15M, a 130.41% increase from fiscal 2022.
- Anika Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $934.00K, a 92.18% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.72M 10-Q · filed 2026-07-29 | $1.72M derived: sum of 3 quarters · filed 2026-07-29 | $1.73M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $1.66M 10-Q · filed 2026-04-30 | $1.66M derived: sum of 2 quarters · filed 2026-04-30 | $1.67M derived: sum of 3 quarters · filed 2026-04-30 | $1.76M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $17.00K derived: sum of 2 quarters · filed 2026-03-03 | $99.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.57M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $95.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.56M 10-Q · filed 2025-11-05 | $1.64M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.55M 10-Q · filed 2026-07-29 | $1.63M derived: sum of 3 quarters · filed 2026-07-29 | $1.65M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $1.47M 10-Q · filed 2026-04-30 | $1.54M derived: sum of 2 quarters · filed 2026-04-30 | $1.56M derived: sum of 3 quarters · filed 2026-04-30 | $1.77M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $98.00K derived: sum of 2 quarters · filed 2026-03-03 | $303.00K derived: sum of 3 quarters · filed 2026-03-03 | $2.60M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $227.00K derived: sum of 2 quarters · filed 2025-11-05 | $2.52M 10-Q · filed 2025-11-05 | $2.52M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $2.50M 10-Q · filed 2025-07-30 | $2.49M derived: sum of 3 quarters · filed 2026-03-03 | $2.60M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-03-31 | $2.30M 10-Q · filed 2025-05-09 | $2.29M derived: sum of 2 quarters · filed 2026-03-03 | $2.40M derived: sum of 3 quarters · filed 2026-03-03 | $2.83M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $103.00K derived: sum of 2 quarters · filed 2026-03-03 | $532.00K derived: sum of 3 quarters · filed 2026-03-03 | $2.15M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $539.00K derived: sum of 2 quarters · filed 2024-11-04 | $2.16M 10-Q · filed 2024-11-04 | $2.16M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-06-30 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.05M 10-Q · filed 2024-08-08 | $2.05M derived: sum of 3 quarters · filed 2025-03-17 | $2.11M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2023-03-31 | $1.62M 10-Q · filed 2024-05-08 | $1.62M derived: sum of 2 quarters · filed 2025-03-17 | $1.68M derived: sum of 3 quarters · filed 2025-03-17 | $1.71M derived: sum of 4 quarters · filed 2025-03-17 | |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $64.00K derived: sum of 2 quarters · filed 2025-03-17 | $88.00K derived: sum of 3 quarters · filed 2025-03-17 | $934.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $89.00K derived: sum of 2 quarters · filed 2023-11-03 | $935.00K 10-Q · filed 2023-11-03 | $998.00K derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $870.00K 10-Q · filed 2023-08-08 | $933.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.00M derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-03-31 | $846.00K 10-Q · filed 2023-05-09 | $909.00K derived: sum of 2 quarters · filed 2024-03-15 | $979.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.00M derived: sum of 4 quarters · filed 2024-03-15 | |
| 2021-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $133.00K derived: sum of 2 quarters · filed 2024-03-15 | $154.00K derived: sum of 3 quarters · filed 2024-03-15 | $486.00K 10-K · filed 2024-03-15 | |
| 2021-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $91.00K derived: sum of 2 quarters · filed 2022-11-09 | $423.00K 10-Q · filed 2022-11-09 | $461.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $353.00K 10-Q · filed 2022-08-04 | $391.00K derived: sum of 3 quarters · filed 2023-03-16 | $415.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-03-31 | $332.00K 10-Q · filed 2022-05-06 | $370.00K derived: sum of 2 quarters · filed 2023-03-16 | $394.00K derived: sum of 3 quarters · filed 2023-03-16 | $453.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2020-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $62.00K derived: sum of 2 quarters · filed 2023-03-16 | $121.00K derived: sum of 3 quarters · filed 2023-03-16 | $262.00K 10-K · filed 2023-03-16 | |
| 2020-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $83.00K derived: sum of 2 quarters · filed 2021-11-05 | $224.00K 10-Q · filed 2021-11-05 | $272.00K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $200.00K 10-Q · filed 2021-08-06 | $248.00K derived: sum of 3 quarters · filed 2022-03-11 | $368.00K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | $141.00K 10-Q · filed 2021-05-07 | $189.00K derived: sum of 2 quarters · filed 2022-03-11 | $309.00K derived: sum of 3 quarters · filed 2022-03-11 | $310.00K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $168.00K derived: sum of 2 quarters · filed 2022-03-11 | $169.00K derived: sum of 3 quarters · filed 2022-03-11 | $293.00K 10-K · filed 2022-03-11 | |
| 2019-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $121.00K derived: sum of 2 quarters · filed 2020-11-05 | $245.00K 10-Q · filed 2020-11-05 | $300.00K derived: sum of 4 quarters · filed 2021-04-26 | |
| 2019-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $125.00K 10-Q · filed 2020-08-07 | $180.00K derived: sum of 3 quarters · filed 2021-04-26 | $180.00K derived: sum of 4 quarters · filed 2021-04-26 | |
| 2019-03-31 | $124.00K 10-Q · filed 2020-05-22 | $179.00K derived: sum of 2 quarters · filed 2021-04-26 | $179.00K derived: sum of 3 quarters · filed 2021-04-26 | $179.00K derived: sum of 4 quarters · filed 2021-04-26 | |
| 2018-12-31 | $55.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $55.00K derived: sum of 2 quarters · filed 2021-04-26 | $55.00K derived: sum of 3 quarters · filed 2021-04-26 | $1.79M 10-K/A · filed 2021-04-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $0.00 derived: sum of 2 quarters · filed 2019-10-28 | $1.74M 10-Q · filed 2019-10-28 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $1.74M 10-Q · filed 2019-07-26 | |||
| 2018-03-31 | $1.74M 10-Q · filed 2019-05-06 | ||||
| 2014-12-31 | $100.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $100.00 derived: sum of 2 quarters · filed 2017-02-24 | $6.35M 10-K · filed 2017-02-24 | $6.35M 10-K · filed 2015-03-13 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $6.35M 10-Q · filed 2015-11-03 | |||
| 2014-06-30 | $6.35M 10-Q · filed 2015-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |